Literature DB >> 29461620

Developing a Core Outcome Set for Trials to Improve Medication Use: Guidelines or Guidance?

Zachary A Marcum1, Michael A Steinman2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29461620      PMCID： PMC6102089          DOI： 10.1111/jgs.15269

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  4 in total

Review 1.  The quality of care. How can it be assessed?

Authors:  A Donabedian
Journal:  JAMA       Date:  1988 Sep 23-30       Impact factor: 56.272

2.  Core Outcome Set for Trials Aimed at Improving the Appropriateness of Polypharmacy in Older People in Primary Care.

Authors:  Audrey Rankin; Cathal A Cadogan; Crist In Ryan; Barbara Clyne; Susan M Smith; Carmel M Hughes
Journal:  J Am Geriatr Soc       Date:  2018-02-20       Impact factor: 5.562

Review 3.  Interventions to improve the appropriate use of polypharmacy for older people.

Authors:  Susan M Patterson; Cathal A Cadogan; Ngaire Kerse; Chris R Cardwell; Marie C Bradley; Cristin Ryan; Carmel Hughes
Journal:  Cochrane Database Syst Rev       Date:  2014-10-07

4.  Developing core outcome sets for clinical trials: issues to consider.

Authors:  Paula R Williamson; Douglas G Altman; Jane M Blazeby; Mike Clarke; Declan Devane; Elizabeth Gargon; Peter Tugwell
Journal:  Trials       Date:  2012-08-06       Impact factor: 2.279
  4 in total
  2 in total

1.  Deprescribing: What is the gold standard? Themes that characterized the discussions at the first Danish symposium on evidence-based deprescribing.

Authors:  Lykke I Kaas Oldenburg; Dagmar Dalin; Anne Mette Drastrup; Charlotte Vermehren
Journal:  Explor Res Clin Soc Pharm       Date:  2022-01-07

2.  Development of a core outcome set for clinical trials aimed at improving antimicrobial stewardship in care homes.

Authors:  Hoa Q Nguyen; Declan T Bradley; Michael M Tunney; Carmel M Hughes
Journal:  Antimicrob Resist Infect Control       Date:  2021-03-09       Impact factor: 4.887
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.